Lead sponsor
Neurocrine Biosciences
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of November 5, 2026.
1
Trials led
1
Ongoing
135
Total enrollment
0
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Trials by status
Not yet recruiting
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Evaluation of NBI-1117567 in Participants With Mild to Moderate Alzheimer's Disease (AD) Taking a Background Acetylcholinesterase Inhibitormild-to-moderate ADPh 2Not yet recruiting135